Norman Waugh

Medicine & Life Sciences

1. Colposcopy 100%
2. Cell Biology 87%
3. Randomized Controlled Trials 61%
4. Systematic Reviews 56%
5. Type 2 Diabetes Mellitus 47%
6. Anxiety 38%
7. Ranibizumab 33%
8. Depression 32%
9. Pioglitazone 32%
10. National Institutes of Health (U.S.) 30%
11. Type 1 Diabetes Mellitus 30%
12. Cervical Intraepithelial Neoplasia 30%
13. Macular Edema 29%
14. Odds Ratio 29%
15. Bevacizumab 28%
16. Insulin 27%
17. Protein-Restricted Diet 22%
18. Cost-Benefit Analysis 21%
19. Biomedical Technology Assessment 21%
20. Young Adult 20%
21. Biopsy 19%
22. Glucose 19%
23. Quality of Life 19%
24. Meta-Analysis 18%
25. Visual Acuity 18%
26. Human papillomavirus 18 18%
27. Body Mass Index 18%
28. Cohort Studies 17%
29. Technology 16%
30. Life Style 13%
31. Kidney 13%
32. Health Care Outcome Assessment 13%
33. Glucose Intolerance 13%
34. Diet 13%
35. Population 12%
36. Human papillomavirus 16 12%
37. Exercise 12%
38. Metformin 11%
39. Costs and Cost Analysis 11%
40. Chronic Kidney Failure 11%
41. Age Groups 10%
42. Libraries 9%
43. Proteins 9%
44. Primary Health Care 9%
45. Pharmaceutical Preparations 8%
46. Diabetic Nephropathies 8%
47. Visual Analog Scale 8%
48. Databases 8%
49. Glomerular Filtration Rate 8%
50. Hyperglycemia 7%